Barree Posted January 21, 2018 Share Posted January 21, 2018 Not to be missed February 20th 2018 Associate Professor Michael Hofman is coming to Prostate Heidelberg in Melbourne to address members on ”Diagnostic & Treatment Paradigms using PET Scans” We have some seats to spare for this Meeting and we extend an invitation to members of our Advanced Group who might be in the Melbourne area on this day to join us for this special event. It’s free - morning tea will be provided but please book in advance by phoning Barry 0400 662 114 or emailing email@example.com Associate Professor Hofman is a nuclear medicine physician at the Centre for Molecular Imaging and Cancer Imaging at the Peter MacCallum Cancer Centre in Melbourne, this is Australia's only public hospital dedicated to cancer treatment, research and education. He is currently involved in the multi-centre randomized clinical trial of Gallium 68 PSMA PET Scans and the trials of the game changing Lutetium 177 PSMA therapy which is about to commence Australia wide. These trials are cutting edge imaging / treatments for Advanced Metastatic Prostate Cancer. Associate Professor Hofman is one of Australia’s — and possibly one of the World’s — leading physicians specializing in Pet & Radio Tracer Scans & Neuroendocrine Tumors & Theranostic treatments like Lutetium177 . Where : - The Uniting Church Meeting Room, Sneddon Street, Ivanhoe - 10.00am sharp There is a car park adjoining the rooms. Parking is free but it can get busy at times. If you can make it don’t miss this golden opportunity to hear Associate Professor Michael Hoffman’s address on these ground - breaking treatments Presented by PROSTATE HEIDELBERG - CANCER SUPPORT GROUP We are Proudly Affiliated with the Prostate Cancer Foundation of Australia and the Cancer Council of Victoria PO Box 241 Ivanhoe Vic 3079 Email :- firstname.lastname@example.org Web Site ttp://www.prostateheidelberg.info/ Link to comment Share on other sites More sharing options...
This topic is now archived and is closed to further replies.